Hjem › Brystkreft › Texas › League City
Kliniske studier for Brystkreft i League City, TX
12 studier for Brystkreft søker deltakere på steder i og rundt League City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RekruttererFase 1
- NEXT Houston, Galveston · 23 mi unna
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- Tranquility Research, Webster · 3 mi unna
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- Tranquil Clinical Research, Webster · 3 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi unna
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruttererFase 2
- Tranquil Clinical Research, Webster · 3 mi unna
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi unna
- University of Texas Medical Branch, Galveston · 23 mi unna
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
RekruttererObservasjonsstudie
- MD Anderson League City, Nassau Bay · 3 mi unna
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Rekrutterer
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mi unna
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RekruttererFrivillige helsepersonell ønskes velkommen
- The University of Texas Medical Branch, Galveston, Galveston · 23 mi unna
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i League City
- Ikke-småcellet lungekreft15 studier
- Metastatisk kreft7 studier
- Ulcerøs kolitt6 studier
- Lungekreft6 studier
- Kolorektal kreft6 studier
- Kreft (alle typer)5 studier
- Eggstokkreft5 studier
- Slag5 studier
- Blærekreft4 studier
- Plateepitelcancer i hode og hals4 studier
- Prostatakreft4 studier
- Post-COVID-tilstander (lang-COVID)3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.